At the Neurocritical Care Society’s (NCS) 22nd Annual Meeting this week, a University of Cincinnati researcher presented Phase 3 clinical trial results finding a new drug is a safe and effective treatment for the most severe and deadly form of epilepsy.
Trial finds new drug safe, effective to treat deadliest form of epilepsy
-
HighlightsFree Dark Web Monitoring Stamps the $17 Million Credentials Markets
-
HighlightsSmart buildings: What happens to our free will when tech makes choices for us?
-
AppsScreenshots have generated new forms of storytelling, from Twitter fan fiction to desktop film
-
HighlightsDarknet markets generate millions in revenue selling stolen personal data, supply chain study finds
-
SecurityPrivacy violations undermine the trustworthiness of the Tim Hortons brand
-
Featured HeadlinesWhy Tesla’s Autopilot crashes spurred the feds to investigate driver-assist technologies – and what that means for the future of self-driving cars
